Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077428
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2004-02-10
Brief Title:
Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced Recurrent or Metastatic Adenoid Cystic Carcinoma Cancer of the Head and Neck
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Salivary Gland Cancer |
| Recurrent Adenoid Cystic Carcinoma of the Oral Cavity |
| Recurrent Salivary Gland Cancer |
| Salivary Gland Adenoid Cystic Carcinoma |
| Stage III Adenoid Cystic Carcinoma of the Oral Cavity |
| Stage III Salivary Gland Cancer |
| Stage IV Adenoid Cystic Carcinoma of the Oral Cavity |
Keywords: